iTeos Therapeutics, Inc(NASDAQ:ITOS) 
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2a receptor that is an open-label Phase 1/2a...
Website: http://www.iteostherapeutics.com
Founded: 2012
Full Time Employees: 55
CEO: Michel Detheux
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-03-04
P
O 6.93
H 6.96
L 6.67
C 6.85
V 410,812
10EMA 6.85
20EMA 6.85
60EMA 6.85
120EMA 6.85
250EMA 6.85